Behcet's disease:: An update on the pathogenesis

被引:0
|
作者
Gül, A [1 ]
机构
[1] Univ Istanbul, Fac Med, Div Rheumatol, Dept Internal Med, TR-34390 Istanbul, Turkey
关键词
Behcet's disease; HLA-B51; complex genetic disease; tumor necrosis factor; pathergy; cytokines; heat shock proteins; gamma delta T-cell; vasculitis; endothelial activation; thrombotic tendency;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease is a chronic inflammatory disorder of unknown etiology. It has long been postulated that immunological abnormalities, which are possibly induced by, microbial pathogens in genetically susceptible individuals, are important in its pathogenesis. Recent findings have both supported the significance of genetic factors and better defined the nature of inflammation in Behcet's disease. Molecular genetic studies have strengthened the primary association of HLA-B51 with Behcet's disease. The exact pathogenic mechanism of the HLA-B51 molecule is still unknown, and its contribution to the overall genetic susceptibility to Behcet's disease is estimated to be less than 20%. Spontaneous and/or induced overexpression of pro-inflammatory cytokines (mainly Th1 type)from various cellular sources seems responsible for the enhanced inflammatory reaction in Behcet's disease, and it may be associated with the genetic susceptibility . An antigen-driven immune response superimposed on this primed-state and induced by heat shock proteins or other peptides,from different strains of streptoccocci or other microbial agents has been suggested to trigger manifestations of Behcet's disease. Endothelial activation/injury and the resultant occlusive vasculopathy may also contribute to the tissue damage.
引用
收藏
页码:S6 / S12
页数:7
相关论文
共 50 条
  • [31] Behcet Disease: An Update for Dermatologists
    Alpsoy, Erkan
    Bozca, Burcin Cansu
    Bilgic, Asli
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 477 - 502
  • [32] Update on the therapy of Behcet disease
    Saleh, Zeinab
    Arayssi, Thurayya
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2014, 5 (03) : 112 - 134
  • [33] Nitric oxide: A possible role in the pathogenesis of Behcet's disease?
    Oliveira, R.
    Banha, J.
    Martins, F.
    Pereira, D.
    Barcelos, F.
    Teixeira, A.
    Patto, J. V.
    Costa, L.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S759 - S759
  • [34] Involvement of innate immunity in the pathogenesis of intestinal Behcet's disease
    Nara, K.
    Kurokawa, M. S.
    Chiba, S.
    Yoshikawa, H.
    Tsukikawa, S.
    Matsuda, T.
    Suzuki, N.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 152 (02): : 245 - 251
  • [35] Infectious agents and pathogenesis of Behcet's disease: An extensive review
    Cheng, Linlin
    Zhan, Haoting
    Liu, Yongmei
    Chen, Hua
    Zhang, Fengchun
    Zheng, Wenjie
    Li, Yongzhe
    CLINICAL IMMUNOLOGY, 2023, 251
  • [36] A Possible Role for Interleukin 37 in the Pathogenesis of Behcet's Disease
    Ye, Z.
    Wang, C.
    Kijlstra, A.
    Zhou, X.
    Yang, P.
    CURRENT MOLECULAR MEDICINE, 2014, 14 (04) : 535 - 542
  • [37] Advances in pathogenesis and treatment of ocular involvement in Behcet's disease
    Lin, Suibin
    Xu, Zhirong
    Lin, Zhiming
    Xie, Baozhao
    Feng, Junmei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Molecular pathogenesis of Parkinson's disease: update
    Saiki, Shinji
    Sato, Shigeto
    Hattori, Nobutaka
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (04): : 430 - 436
  • [39] Parkinson's disease: an update on pathogenesis and treatment
    Foltynie, Tom
    Kahan, Joshua
    JOURNAL OF NEUROLOGY, 2013, 260 (05) : 1433 - 1440
  • [40] Autoimmune Addison's disease - An update on pathogenesis
    Hellesen, Alexander
    Bratland, Eirik
    Husebye, Eystein S.
    ANNALES D ENDOCRINOLOGIE, 2018, 79 (03) : 157 - 163